Hotline: +86-18022463983    020-85206863

Global Animal Gut Health Products Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: 2025-10-08   |   Pages: 203   |   Tables: 198   |  Medical Care

The global Animal Gut Health Products market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Animal Gut Health Products are supplements or feed additives designed to support and improve the digestive health of animals. These products often contain probiotics, prebiotics, enzymes, and other bioactive ingredients that help balance the gut microbiome, enhance nutrient absorption, and promote overall gut function. By maintaining a healthy digestive system, these products aim to boost immunity, prevent gastrointestinal disorders, and improve the growth, performance, and well-being of livestock and pets. They are commonly used in animal husbandry and veterinary medicine to promote better health and productivity.
From a downstream perspective, Poultry accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Animal Gut Health Products leading manufacturers including DSM, Novonesis, Alltech, Evonik, Cargill, Danisco Animal Nutrition & Health, Kemin Industries, Novus International, Lallemand, Lesaffre, etc., dominate supply; the top five capture approximately % of global revenue, with DSM leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Animal Gut Health Products market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
DSM
Novonesis
Alltech
Evonik
Cargill
Danisco Animal Nutrition & Health
Kemin Industries
Novus International
Lallemand
Lesaffre
EW Nutrition
Eastman
Balchem
Biochem
Amlan International
Merck Animal Health
Celtic Sea Minerals
Maxx Performance
BEWITAL
Native Microbials
Orffa
Biorigin
AB Vista
Biofeed Technology
Impextraco
Nuproxa
Bioseutica
Asahi Biocycle
Trouw Nutrition
Alivira Animal Health
Perstorp
Olus
Maximum Animal Health
Innovad
Bluestar Adisseo
VTR BioTech
Qingdao Vland Biotech
Guangzhou Insighter Biotechnology
Segment by Type
Probiotics
Prebiotics
Enzymes
Organic Acids
Phytogenics
Others
Segment by Application
Poultry
Swine
Ruminants
Aquaculture
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Animal Gut Health Products study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Study Coverage
1.1 Introduction to Animal Gut Health Products: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Animal Gut Health Products Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Probiotics
1.2.3 Prebiotics
1.2.4 Enzymes
1.2.5 Organic Acids
1.2.6 Phytogenics
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global Animal Gut Health Products Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Poultry
1.3.3 Swine
1.3.4 Ruminants
1.3.5 Aquaculture
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Animal Gut Health Products Revenue Estimates and Forecasts 2020-2031
2.2 Global Animal Gut Health Products Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Animal Gut Health Products Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Animal Gut Health Products Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Probiotics Market Size by Players
3.3.2 Prebiotics Market Size by Players
3.3.3 Enzymes Market Size by Players
3.3.4 Organic Acids Market Size by Players
3.3.5 Phytogenics Market Size by Players
3.3.6 Others Market Size by Players
3.4 Global Animal Gut Health Products Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Animal Gut Health Products Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Animal Gut Health Products Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Animal Gut Health Products Market Size by Type (2020-2031)
6.4 North America Animal Gut Health Products Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Animal Gut Health Products Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Animal Gut Health Products Market Size by Type (2020-2031)
7.4 Europe Animal Gut Health Products Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Animal Gut Health Products Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Animal Gut Health Products Market Size by Type (2020-2031)
8.4 Asia-Pacific Animal Gut Health Products Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Animal Gut Health Products Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Animal Gut Health Products Market Size by Type (2020-2031)
9.4 Central and South America Animal Gut Health Products Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Animal Gut Health Products Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Animal Gut Health Products Market Size by Type (2020-2031)
10.4 Middle East and Africa Animal Gut Health Products Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Animal Gut Health Products Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 DSM
11.1.1 DSM Corporation Information
11.1.2 DSM Business Overview
11.1.3 DSM Animal Gut Health Products Product Features and Attributes
11.1.4 DSM Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.1.5 DSM Animal Gut Health Products Revenue by Product in 2024
11.1.6 DSM Animal Gut Health Products Revenue by Application in 2024
11.1.7 DSM Animal Gut Health Products Revenue by Geographic Area in 2024
11.1.8 DSM Animal Gut Health Products SWOT Analysis
11.1.9 DSM Recent Developments
11.2 Novonesis
11.2.1 Novonesis Corporation Information
11.2.2 Novonesis Business Overview
11.2.3 Novonesis Animal Gut Health Products Product Features and Attributes
11.2.4 Novonesis Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.2.5 Novonesis Animal Gut Health Products Revenue by Product in 2024
11.2.6 Novonesis Animal Gut Health Products Revenue by Application in 2024
11.2.7 Novonesis Animal Gut Health Products Revenue by Geographic Area in 2024
11.2.8 Novonesis Animal Gut Health Products SWOT Analysis
11.2.9 Novonesis Recent Developments
11.3 Alltech
11.3.1 Alltech Corporation Information
11.3.2 Alltech Business Overview
11.3.3 Alltech Animal Gut Health Products Product Features and Attributes
11.3.4 Alltech Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.3.5 Alltech Animal Gut Health Products Revenue by Product in 2024
11.3.6 Alltech Animal Gut Health Products Revenue by Application in 2024
11.3.7 Alltech Animal Gut Health Products Revenue by Geographic Area in 2024
11.3.8 Alltech Animal Gut Health Products SWOT Analysis
11.3.9 Alltech Recent Developments
11.4 Evonik
11.4.1 Evonik Corporation Information
11.4.2 Evonik Business Overview
11.4.3 Evonik Animal Gut Health Products Product Features and Attributes
11.4.4 Evonik Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.4.5 Evonik Animal Gut Health Products Revenue by Product in 2024
11.4.6 Evonik Animal Gut Health Products Revenue by Application in 2024
11.4.7 Evonik Animal Gut Health Products Revenue by Geographic Area in 2024
11.4.8 Evonik Animal Gut Health Products SWOT Analysis
11.4.9 Evonik Recent Developments
11.5 Cargill
11.5.1 Cargill Corporation Information
11.5.2 Cargill Business Overview
11.5.3 Cargill Animal Gut Health Products Product Features and Attributes
11.5.4 Cargill Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.5.5 Cargill Animal Gut Health Products Revenue by Product in 2024
11.5.6 Cargill Animal Gut Health Products Revenue by Application in 2024
11.5.7 Cargill Animal Gut Health Products Revenue by Geographic Area in 2024
11.5.8 Cargill Animal Gut Health Products SWOT Analysis
11.5.9 Cargill Recent Developments
11.6 Danisco Animal Nutrition & Health
11.6.1 Danisco Animal Nutrition & Health Corporation Information
11.6.2 Danisco Animal Nutrition & Health Business Overview
11.6.3 Danisco Animal Nutrition & Health Animal Gut Health Products Product Features and Attributes
11.6.4 Danisco Animal Nutrition & Health Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.6.5 Danisco Animal Nutrition & Health Recent Developments
11.7 Kemin Industries
11.7.1 Kemin Industries Corporation Information
11.7.2 Kemin Industries Business Overview
11.7.3 Kemin Industries Animal Gut Health Products Product Features and Attributes
11.7.4 Kemin Industries Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.7.5 Kemin Industries Recent Developments
11.8 Novus International
11.8.1 Novus International Corporation Information
11.8.2 Novus International Business Overview
11.8.3 Novus International Animal Gut Health Products Product Features and Attributes
11.8.4 Novus International Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.8.5 Novus International Recent Developments
11.9 Lallemand
11.9.1 Lallemand Corporation Information
11.9.2 Lallemand Business Overview
11.9.3 Lallemand Animal Gut Health Products Product Features and Attributes
11.9.4 Lallemand Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.9.5 Lallemand Recent Developments
11.10 Lesaffre
11.10.1 Lesaffre Corporation Information
11.10.2 Lesaffre Business Overview
11.10.3 Lesaffre Animal Gut Health Products Product Features and Attributes
11.10.4 Lesaffre Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 EW Nutrition
11.11.1 EW Nutrition Corporation Information
11.11.2 EW Nutrition Business Overview
11.11.3 EW Nutrition Animal Gut Health Products Product Features and Attributes
11.11.4 EW Nutrition Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.11.5 EW Nutrition Recent Developments
11.12 Eastman
11.12.1 Eastman Corporation Information
11.12.2 Eastman Business Overview
11.12.3 Eastman Animal Gut Health Products Product Features and Attributes
11.12.4 Eastman Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.12.5 Eastman Recent Developments
11.13 Balchem
11.13.1 Balchem Corporation Information
11.13.2 Balchem Business Overview
11.13.3 Balchem Animal Gut Health Products Product Features and Attributes
11.13.4 Balchem Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.13.5 Balchem Recent Developments
11.14 Biochem
11.14.1 Biochem Corporation Information
11.14.2 Biochem Business Overview
11.14.3 Biochem Animal Gut Health Products Product Features and Attributes
11.14.4 Biochem Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.14.5 Biochem Recent Developments
11.15 Amlan International
11.15.1 Amlan International Corporation Information
11.15.2 Amlan International Business Overview
11.15.3 Amlan International Animal Gut Health Products Product Features and Attributes
11.15.4 Amlan International Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.15.5 Amlan International Recent Developments
11.16 Merck Animal Health
11.16.1 Merck Animal Health Corporation Information
11.16.2 Merck Animal Health Business Overview
11.16.3 Merck Animal Health Animal Gut Health Products Product Features and Attributes
11.16.4 Merck Animal Health Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.16.5 Merck Animal Health Recent Developments
11.17 Celtic Sea Minerals
11.17.1 Celtic Sea Minerals Corporation Information
11.17.2 Celtic Sea Minerals Business Overview
11.17.3 Celtic Sea Minerals Animal Gut Health Products Product Features and Attributes
11.17.4 Celtic Sea Minerals Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.17.5 Celtic Sea Minerals Recent Developments
11.18 Maxx Performance
11.18.1 Maxx Performance Corporation Information
11.18.2 Maxx Performance Business Overview
11.18.3 Maxx Performance Animal Gut Health Products Product Features and Attributes
11.18.4 Maxx Performance Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.18.5 Maxx Performance Recent Developments
11.19 BEWITAL
11.19.1 BEWITAL Corporation Information
11.19.2 BEWITAL Business Overview
11.19.3 BEWITAL Animal Gut Health Products Product Features and Attributes
11.19.4 BEWITAL Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.19.5 BEWITAL Recent Developments
11.20 Native Microbials
11.20.1 Native Microbials Corporation Information
11.20.2 Native Microbials Business Overview
11.20.3 Native Microbials Animal Gut Health Products Product Features and Attributes
11.20.4 Native Microbials Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.20.5 Native Microbials Recent Developments
11.21 Orffa
11.21.1 Orffa Corporation Information
11.21.2 Orffa Business Overview
11.21.3 Orffa Animal Gut Health Products Product Features and Attributes
11.21.4 Orffa Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.21.5 Orffa Recent Developments
11.22 Biorigin
11.22.1 Biorigin Corporation Information
11.22.2 Biorigin Business Overview
11.22.3 Biorigin Animal Gut Health Products Product Features and Attributes
11.22.4 Biorigin Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.22.5 Biorigin Recent Developments
11.23 AB Vista
11.23.1 AB Vista Corporation Information
11.23.2 AB Vista Business Overview
11.23.3 AB Vista Animal Gut Health Products Product Features and Attributes
11.23.4 AB Vista Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.23.5 AB Vista Recent Developments
11.24 Biofeed Technology
11.24.1 Biofeed Technology Corporation Information
11.24.2 Biofeed Technology Business Overview
11.24.3 Biofeed Technology Animal Gut Health Products Product Features and Attributes
11.24.4 Biofeed Technology Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.24.5 Biofeed Technology Recent Developments
11.25 Impextraco
11.25.1 Impextraco Corporation Information
11.25.2 Impextraco Business Overview
11.25.3 Impextraco Animal Gut Health Products Product Features and Attributes
11.25.4 Impextraco Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.25.5 Impextraco Recent Developments
11.26 Nuproxa
11.26.1 Nuproxa Corporation Information
11.26.2 Nuproxa Business Overview
11.26.3 Nuproxa Animal Gut Health Products Product Features and Attributes
11.26.4 Nuproxa Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.26.5 Nuproxa Recent Developments
11.27 Bioseutica
11.27.1 Bioseutica Corporation Information
11.27.2 Bioseutica Business Overview
11.27.3 Bioseutica Animal Gut Health Products Product Features and Attributes
11.27.4 Bioseutica Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.27.5 Bioseutica Recent Developments
11.28 Asahi Biocycle
11.28.1 Asahi Biocycle Corporation Information
11.28.2 Asahi Biocycle Business Overview
11.28.3 Asahi Biocycle Animal Gut Health Products Product Features and Attributes
11.28.4 Asahi Biocycle Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.28.5 Asahi Biocycle Recent Developments
11.29 Trouw Nutrition
11.29.1 Trouw Nutrition Corporation Information
11.29.2 Trouw Nutrition Business Overview
11.29.3 Trouw Nutrition Animal Gut Health Products Product Features and Attributes
11.29.4 Trouw Nutrition Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.29.5 Trouw Nutrition Recent Developments
11.30 Alivira Animal Health
11.30.1 Alivira Animal Health Corporation Information
11.30.2 Alivira Animal Health Business Overview
11.30.3 Alivira Animal Health Animal Gut Health Products Product Features and Attributes
11.30.4 Alivira Animal Health Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.30.5 Alivira Animal Health Recent Developments
11.31 Perstorp
11.31.1 Perstorp Corporation Information
11.31.2 Perstorp Business Overview
11.31.3 Perstorp Animal Gut Health Products Product Features and Attributes
11.31.4 Perstorp Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.31.5 Perstorp Recent Developments
11.32 Olus
11.32.1 Olus Corporation Information
11.32.2 Olus Business Overview
11.32.3 Olus Animal Gut Health Products Product Features and Attributes
11.32.4 Olus Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.32.5 Olus Recent Developments
11.33 Maximum Animal Health
11.33.1 Maximum Animal Health Corporation Information
11.33.2 Maximum Animal Health Business Overview
11.33.3 Maximum Animal Health Animal Gut Health Products Product Features and Attributes
11.33.4 Maximum Animal Health Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.33.5 Maximum Animal Health Recent Developments
11.34 Innovad
11.34.1 Innovad Corporation Information
11.34.2 Innovad Business Overview
11.34.3 Innovad Animal Gut Health Products Product Features and Attributes
11.34.4 Innovad Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.34.5 Innovad Recent Developments
11.35 Bluestar Adisseo
11.35.1 Bluestar Adisseo Corporation Information
11.35.2 Bluestar Adisseo Business Overview
11.35.3 Bluestar Adisseo Animal Gut Health Products Product Features and Attributes
11.35.4 Bluestar Adisseo Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.35.5 Bluestar Adisseo Recent Developments
11.36 VTR BioTech
11.36.1 VTR BioTech Corporation Information
11.36.2 VTR BioTech Business Overview
11.36.3 VTR BioTech Animal Gut Health Products Product Features and Attributes
11.36.4 VTR BioTech Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.36.5 VTR BioTech Recent Developments
11.37 Qingdao Vland Biotech
11.37.1 Qingdao Vland Biotech Corporation Information
11.37.2 Qingdao Vland Biotech Business Overview
11.37.3 Qingdao Vland Biotech Animal Gut Health Products Product Features and Attributes
11.37.4 Qingdao Vland Biotech Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.37.5 Qingdao Vland Biotech Recent Developments
11.38 Guangzhou Insighter Biotechnology
11.38.1 Guangzhou Insighter Biotechnology Corporation Information
11.38.2 Guangzhou Insighter Biotechnology Business Overview
11.38.3 Guangzhou Insighter Biotechnology Animal Gut Health Products Product Features and Attributes
11.38.4 Guangzhou Insighter Biotechnology Animal Gut Health Products Revenue and Gross Margin (2020-2025)
11.38.5 Guangzhou Insighter Biotechnology Recent Developments
12 Animal Gut Health ProductsIndustry Chain Analysis
12.1 Animal Gut Health Products Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Animal Gut Health Products Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Animal Gut Health Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Animal Gut Health Products Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Animal Gut Health Products Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Animal Gut Health Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Animal Gut Health Products Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Animal Gut Health Products Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Animal Gut Health Products Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Animal Gut Health Products Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Animal Gut Health Products by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Gut Health Products as of 2024)
Table 11. Global Animal Gut Health Products Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Animal Gut Health Products Companies Headquarters
Table 13. Global Animal Gut Health Products Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Animal Gut Health Products Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Animal Gut Health Products Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Animal Gut Health Products Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Animal Gut Health Products Revenue by Application (2026-2031) & (US$ Million)
Table 21. Animal Gut Health Products High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Animal Gut Health Products Growth Accelerators and Market Barriers
Table 25. North America Animal Gut Health Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Animal Gut Health Products Growth Accelerators and Market Barriers
Table 27. Europe Animal Gut Health Products Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Animal Gut Health Products Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Animal Gut Health Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Animal Gut Health Products Investment Opportunities and Key Challenges
Table 31. Central and South America Animal Gut Health Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Animal Gut Health Products Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Animal Gut Health Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. DSM Corporation Information
Table 35. DSM Description and Major Businesses
Table 36. DSM Product Features and Attributes
Table 37. DSM Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. DSM Revenue Proportion by Product in 2024
Table 39. DSM Revenue Proportion by Application in 2024
Table 40. DSM Revenue Proportion by Geographic Area in 2024
Table 41. DSM Animal Gut Health Products SWOT Analysis
Table 42. DSM Recent Developments
Table 43. Novonesis Corporation Information
Table 44. Novonesis Description and Major Businesses
Table 45. Novonesis Product Features and Attributes
Table 46. Novonesis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Novonesis Revenue Proportion by Product in 2024
Table 48. Novonesis Revenue Proportion by Application in 2024
Table 49. Novonesis Revenue Proportion by Geographic Area in 2024
Table 50. Novonesis Animal Gut Health Products SWOT Analysis
Table 51. Novonesis Recent Developments
Table 52. Alltech Corporation Information
Table 53. Alltech Description and Major Businesses
Table 54. Alltech Product Features and Attributes
Table 55. Alltech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Alltech Revenue Proportion by Product in 2024
Table 57. Alltech Revenue Proportion by Application in 2024
Table 58. Alltech Revenue Proportion by Geographic Area in 2024
Table 59. Alltech Animal Gut Health Products SWOT Analysis
Table 60. Alltech Recent Developments
Table 61. Evonik Corporation Information
Table 62. Evonik Description and Major Businesses
Table 63. Evonik Product Features and Attributes
Table 64. Evonik Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Evonik Revenue Proportion by Product in 2024
Table 66. Evonik Revenue Proportion by Application in 2024
Table 67. Evonik Revenue Proportion by Geographic Area in 2024
Table 68. Evonik Animal Gut Health Products SWOT Analysis
Table 69. Evonik Recent Developments
Table 70. Cargill Corporation Information
Table 71. Cargill Description and Major Businesses
Table 72. Cargill Product Features and Attributes
Table 73. Cargill Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Cargill Revenue Proportion by Product in 2024
Table 75. Cargill Revenue Proportion by Application in 2024
Table 76. Cargill Revenue Proportion by Geographic Area in 2024
Table 77. Cargill Animal Gut Health Products SWOT Analysis
Table 78. Cargill Recent Developments
Table 79. Danisco Animal Nutrition & Health Corporation Information
Table 80. Danisco Animal Nutrition & Health Description and Major Businesses
Table 81. Danisco Animal Nutrition & Health Product Features and Attributes
Table 82. Danisco Animal Nutrition & Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Danisco Animal Nutrition & Health Recent Developments
Table 84. Kemin Industries Corporation Information
Table 85. Kemin Industries Description and Major Businesses
Table 86. Kemin Industries Product Features and Attributes
Table 87. Kemin Industries Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Kemin Industries Recent Developments
Table 89. Novus International Corporation Information
Table 90. Novus International Description and Major Businesses
Table 91. Novus International Product Features and Attributes
Table 92. Novus International Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Novus International Recent Developments
Table 94. Lallemand Corporation Information
Table 95. Lallemand Description and Major Businesses
Table 96. Lallemand Product Features and Attributes
Table 97. Lallemand Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Lallemand Recent Developments
Table 99. Lesaffre Corporation Information
Table 100. Lesaffre Description and Major Businesses
Table 101. Lesaffre Product Features and Attributes
Table 102. Lesaffre Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Lesaffre Recent Developments
Table 104. EW Nutrition Corporation Information
Table 105. EW Nutrition Description and Major Businesses
Table 106. EW Nutrition Product Features and Attributes
Table 107. EW Nutrition Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. EW Nutrition Recent Developments
Table 109. Eastman Corporation Information
Table 110. Eastman Description and Major Businesses
Table 111. Eastman Product Features and Attributes
Table 112. Eastman Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Eastman Recent Developments
Table 114. Balchem Corporation Information
Table 115. Balchem Description and Major Businesses
Table 116. Balchem Product Features and Attributes
Table 117. Balchem Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Balchem Recent Developments
Table 119. Biochem Corporation Information
Table 120. Biochem Description and Major Businesses
Table 121. Biochem Product Features and Attributes
Table 122. Biochem Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Biochem Recent Developments
Table 124. Amlan International Corporation Information
Table 125. Amlan International Description and Major Businesses
Table 126. Amlan International Product Features and Attributes
Table 127. Amlan International Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Amlan International Recent Developments
Table 129. Merck Animal Health Corporation Information
Table 130. Merck Animal Health Description and Major Businesses
Table 131. Merck Animal Health Product Features and Attributes
Table 132. Merck Animal Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Merck Animal Health Recent Developments
Table 134. Celtic Sea Minerals Corporation Information
Table 135. Celtic Sea Minerals Description and Major Businesses
Table 136. Celtic Sea Minerals Product Features and Attributes
Table 137. Celtic Sea Minerals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Celtic Sea Minerals Recent Developments
Table 139. Maxx Performance Corporation Information
Table 140. Maxx Performance Description and Major Businesses
Table 141. Maxx Performance Product Features and Attributes
Table 142. Maxx Performance Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Maxx Performance Recent Developments
Table 144. BEWITAL Corporation Information
Table 145. BEWITAL Description and Major Businesses
Table 146. BEWITAL Product Features and Attributes
Table 147. BEWITAL Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. BEWITAL Recent Developments
Table 149. Native Microbials Corporation Information
Table 150. Native Microbials Description and Major Businesses
Table 151. Native Microbials Product Features and Attributes
Table 152. Native Microbials Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Native Microbials Recent Developments
Table 154. Orffa Corporation Information
Table 155. Orffa Description and Major Businesses
Table 156. Orffa Product Features and Attributes
Table 157. Orffa Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Orffa Recent Developments
Table 159. Biorigin Corporation Information
Table 160. Biorigin Description and Major Businesses
Table 161. Biorigin Product Features and Attributes
Table 162. Biorigin Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. Biorigin Recent Developments
Table 164. AB Vista Corporation Information
Table 165. AB Vista Description and Major Businesses
Table 166. AB Vista Product Features and Attributes
Table 167. AB Vista Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. AB Vista Recent Developments
Table 169. Biofeed Technology Corporation Information
Table 170. Biofeed Technology Description and Major Businesses
Table 171. Biofeed Technology Product Features and Attributes
Table 172. Biofeed Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 173. Biofeed Technology Recent Developments
Table 174. Impextraco Corporation Information
Table 175. Impextraco Description and Major Businesses
Table 176. Impextraco Product Features and Attributes
Table 177. Impextraco Revenue (US$ Million) and Gross Margin (2020-2025)
Table 178. Impextraco Recent Developments
Table 179. Nuproxa Corporation Information
Table 180. Nuproxa Description and Major Businesses
Table 181. Nuproxa Product Features and Attributes
Table 182. Nuproxa Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. Nuproxa Recent Developments
Table 184. Bioseutica Corporation Information
Table 185. Bioseutica Description and Major Businesses
Table 186. Bioseutica Product Features and Attributes
Table 187. Bioseutica Revenue (US$ Million) and Gross Margin (2020-2025)
Table 188. Bioseutica Recent Developments
Table 189. Asahi Biocycle Corporation Information
Table 190. Asahi Biocycle Description and Major Businesses
Table 191. Asahi Biocycle Product Features and Attributes
Table 192. Asahi Biocycle Revenue (US$ Million) and Gross Margin (2020-2025)
Table 193. Asahi Biocycle Recent Developments
Table 194. Trouw Nutrition Corporation Information
Table 195. Trouw Nutrition Description and Major Businesses
Table 196. Trouw Nutrition Product Features and Attributes
Table 197. Trouw Nutrition Revenue (US$ Million) and Gross Margin (2020-2025)
Table 198. Trouw Nutrition Recent Developments
Table 199. Alivira Animal Health Corporation Information
Table 200. Alivira Animal Health Description and Major Businesses
Table 201. Alivira Animal Health Product Features and Attributes
Table 202. Alivira Animal Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 203. Alivira Animal Health Recent Developments
Table 204. Perstorp Corporation Information
Table 205. Perstorp Description and Major Businesses
Table 206. Perstorp Product Features and Attributes
Table 207. Perstorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 208. Perstorp Recent Developments
Table 209. Olus Corporation Information
Table 210. Olus Description and Major Businesses
Table 211. Olus Product Features and Attributes
Table 212. Olus Revenue (US$ Million) and Gross Margin (2020-2025)
Table 213. Olus Recent Developments
Table 214. Maximum Animal Health Corporation Information
Table 215. Maximum Animal Health Description and Major Businesses
Table 216. Maximum Animal Health Product Features and Attributes
Table 217. Maximum Animal Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 218. Maximum Animal Health Recent Developments
Table 219. Innovad Corporation Information
Table 220. Innovad Description and Major Businesses
Table 221. Innovad Product Features and Attributes
Table 222. Innovad Revenue (US$ Million) and Gross Margin (2020-2025)
Table 223. Innovad Recent Developments
Table 224. Bluestar Adisseo Corporation Information
Table 225. Bluestar Adisseo Description and Major Businesses
Table 226. Bluestar Adisseo Product Features and Attributes
Table 227. Bluestar Adisseo Revenue (US$ Million) and Gross Margin (2020-2025)
Table 228. Bluestar Adisseo Recent Developments
Table 229. VTR BioTech Corporation Information
Table 230. VTR BioTech Description and Major Businesses
Table 231. VTR BioTech Product Features and Attributes
Table 232. VTR BioTech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 233. VTR BioTech Recent Developments
Table 234. Qingdao Vland Biotech Corporation Information
Table 235. Qingdao Vland Biotech Description and Major Businesses
Table 236. Qingdao Vland Biotech Product Features and Attributes
Table 237. Qingdao Vland Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 238. Qingdao Vland Biotech Recent Developments
Table 239. Guangzhou Insighter Biotechnology Corporation Information
Table 240. Guangzhou Insighter Biotechnology Description and Major Businesses
Table 241. Guangzhou Insighter Biotechnology Product Features and Attributes
Table 242. Guangzhou Insighter Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 243. Guangzhou Insighter Biotechnology Recent Developments
Table 244. Raw Materials Key Suppliers
Table 245. Distributors List
Table 246. Market Trends and Market Evolution
Table 247. Market Drivers and Opportunities
Table 248. Market Challenges, Risks, and Restraints
Table 249. Research Programs/Design for This Report
Table 250. Key Data Information from Secondary Sources
Table 251. Key Data Information from Primary Sources


List of Figures
Figure 1. Animal Gut Health Products Product Picture
Figure 2. Global Animal Gut Health Products Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Probiotics Product Picture
Figure 4. Prebiotics Product Picture
Figure 5. Enzymes Product Picture
Figure 6. Organic Acids Product Picture
Figure 7. Phytogenics Product Picture
Figure 8. Others Product Picture
Figure 9. Global Animal Gut Health Products Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 10. Poultry
Figure 11. Swine
Figure 12. Ruminants
Figure 13. Aquaculture
Figure 14. Animal Gut Health Products Report Years Considered
Figure 15. Global Animal Gut Health Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 17. Global Animal Gut Health Products Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 18. Global Animal Gut Health Products Revenue Market Share by Region (2020-2031)
Figure 19. Global Animal Gut Health Products Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Probiotics Revenue Market Share by Player in 2024
Figure 22. Prebiotics Revenue Market Share by Player in 2024
Figure 23. Enzymes Revenue Market Share by Player in 2024
Figure 24. Organic Acids Revenue Market Share by Player in 2024
Figure 25. Phytogenics Revenue Market Share by Player in 2024
Figure 26. Others Revenue Market Share by Player in 2024
Figure 27. Global Animal Gut Health Products Revenue Market Share by Type (2020-2031)
Figure 28. Global Animal Gut Health Products Revenue Market Share by Application (2020-2031)
Figure 29. North America Animal Gut Health Products Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Players Animal Gut Health Products Revenue (US$ Million) in 2024
Figure 31. North America Animal Gut Health Products Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Animal Gut Health Products Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Animal Gut Health Products Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Players Animal Gut Health Products Revenue (US$ Million) in 2024
Figure 38. Europe Animal Gut Health Products Revenue (US$ Million) by Type (2020-2031)
Figure 39. Europe Animal Gut Health Products Revenue (US$ Million) by Application (2020-2031)
Figure 40. Germany Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 41. France Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 42. U.K. Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 43. Italy Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 44. Russia Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 45. Asia-Pacific Animal Gut Health Products Revenue YoY (2020-2031) & (US$ Million)
Figure 46. Asia-Pacific Top 8 Players Animal Gut Health Products Revenue (US$ Million) in 2024
Figure 47. Asia-Pacific Animal Gut Health Products Revenue (US$ Million) by Type (2020-2031)
Figure 48. Asia-Pacific Animal Gut Health Products Revenue (US$ Million) by Application (2020-2031)
Figure 49. Indonesia Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 50. Japan Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 51. South Korea Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 52. Australia Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 53. India Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 54. Indonesia Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 55. Vietnam Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 56. Malaysia Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 57. Philippines Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 58. Singapore Animal Gut Health Products Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Animal Gut Health Products Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Central and South America Top 5 Players Animal Gut Health Products Revenue (US$ Million) in 2024
Figure 61. Central and South America Animal Gut Health Products Revenue (US$ Million) by Type (2020-2031)
Figure 62. Central and South America Animal Gut Health Products Revenue (US$ Million) by Application (2020-2031)
Figure 63. Brazil Animal Gut Health Products Revenue (2020-2025) & (US$ Million)
Figure 64. Argentina Animal Gut Health Products Revenue (2020-2025) & (US$ Million)
Figure 65. Middle East and Africa Animal Gut Health Products Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Middle East and Africa Top 5 Players Animal Gut Health Products Revenue (US$ Million) in 2024
Figure 67. South America Animal Gut Health Products Revenue (US$ Million) by Type (2020-2031)
Figure 68. Middle East and Africa Animal Gut Health Products Revenue (US$ Million) by Application (2020-2031)
Figure 69. GCC Countries Animal Gut Health Products Revenue (2020-2025) & (US$ Million)
Figure 70. Israel Animal Gut Health Products Revenue (2020-2025) & (US$ Million)
Figure 71. Egypt Animal Gut Health Products Revenue (2020-2025) & (US$ Million)
Figure 72. South Africa Animal Gut Health Products Revenue (2020-2025) & (US$ Million)
Figure 73. Animal Gut Health Products Industry Chain Mapping
Figure 74. Channels of Distribution (Direct Vs Distribution)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

Our Clients